keyword
https://read.qxmd.com/read/38649650/cardiovascular-screening-outcomes-in-the-dutch-survivorship-care-program-for-hodgkin-lymphoma-survivors
#1
JOURNAL ARTICLE
Eline M J Lammers, Annelies Nijdam, Josée M Zijlstra, Cécile P M Janus, Roel J de Weijer, Yolande Appelman, Olivier C Manintveld, Arco J Teske, Flora E van Leeuwen, Berthe M P Aleman
PURPOSE: Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular disease (CVD) due to former lymphoma treatment. In 2013, cardiovascular screening for 5-year HL survivors according to national guidelines was implemented in Dutch survivorship clinics. We aim to assess the following: (1) adherence to screening guidelines and (2) the yield of (risk factors for) CVD in the screening program. METHODS: The study population consisted of 5-year HL survivors who received survivorship care at three University Medical Centers from 2013 to 2016 through 2021...
April 23, 2024: Journal of Cancer Survivorship: Research and Practice
https://read.qxmd.com/read/38626097/cardiac-mri-enriched-phenomapping-classification-and-differential-treatment-outcomes-in-patients-with-ischemic-cardiomyopathy
#2
JOURNAL ARTICLE
Deborah H Kwon, Shuaiqi Huang, Mustafa Turkmani, Donna Salam, Danah Al-Dieri, Tom Kai Ming Wang, Samir R Kapadia, Amar Krishnaswamy, Marc Gillinov, Lars G Svensson, Richard A Grimm, W H Wilson Tang, David Chen, Christopher T Nguyen, Xiaofeng Wang
BACKGROUND: Significant controversy continues to confound patient selection and referral for revascularization and mitral valve intervention in patients with ischemic cardiomyopathy (ICM). Cardiac magnetic resonance (CMR) enables comprehensive phenotyping with gold-standard tissue characterization and volumetric/functional measures. Therefore, we sought to determine the impact of CMR-enriched phenomapping patients with ICM to identify differential outcomes following surgical revascularization and surgical mitral valve intervention (sMVi)...
April 2024: Circulation. Cardiovascular Imaging
https://read.qxmd.com/read/38626077/large-animal-translational-validation-of-3-mitral-valve-repair-operations-for-mitral-regurgitation-using-a-mitral-valve-prolapse-model-a-comprehensive-in-vivo-biomechanical-engineering-analysis
#3
JOURNAL ARTICLE
Yuanjia Zhu, Shin Yajima, Matthew H Park, Akshay Venkatesh, Charles J Stark, Nicholas A Tran, Sabrina K Walsh, Sidarth Ethiraj, Robert J Wilkerson, Luca E Lin, Seung Hyun Lee, Kate Y Gates, Justin D Arthur, Sam W Baker, Danielle M Mullis, Catherine A Wu, Shun Harima, Bipul Pokhrel, Dominique Resuello, Hunter Bergamasco, Matthew A Wu, Basil M Baccouche, Pearly K Pandya, Stefan Elde, Hanjay Wang, Y Joseph Woo
BACKGROUND: Various mitral repair techniques have been described. Though these repair techniques can be highly effective when performed correctly in suitable patients, limited quantitative biomechanical data are available. Validation and thorough biomechanical evaluation of these repair techniques from translational large animal in vivo studies in a standardized, translatable fashion are lacking. We sought to evaluate and validate biomechanical differences among different mitral repair techniques and further optimize repair operations using a large animal mitral valve prolapse model...
April 2024: Circulation. Cardiovascular Interventions
https://read.qxmd.com/read/38594875/actn1-related-thrombocytopenia-homozygosity-for-an-actn1-variant-results-in-a-more-severe-phenotype
#4
JOURNAL ARTICLE
Melania Eva Zanchetta, Serena Barozzi, Federica Isidori, Caterina Marconi, Loredana Farinasso, Roberta Bottega, Anna Savoia, Alessandro Pecci, Michela Faleschini
ACTN1-related thrombocytopenia is a rare disorder caused by heterozygous variants in the ACTN1 gene characterized by macrothrombocytopenia and mild bleeding tendency. We describe for the first time two patients affected with ACTN1-RT caused by a homozygous variant in ACTN1 (c.982G>A) with mild heart valve defects unexplained by any other genetic variants investigated by WES. Within the reported family, the homozygous sisters have moderate thrombocytopenia and marked platelet macrocytosis with giant platelets, revealing a more severe haematological phenotype compared to their heterozygous relatives and highlighting a significant effect of allelic burden on platelet size...
April 9, 2024: British Journal of Haematology
https://read.qxmd.com/read/38594763/unusual-origins-of-cardiac-insufficiency-a-case-of-iliac-arteriovenous-fistula-post-spinal-disc-surgery
#5
JOURNAL ARTICLE
Zheng-Ji Chen, Nouman Ahmad, Ling-Jin Huang
In this case report, we present the unique and intriguing case of a 57-year-old man who experienced exertional palpitations and shortness of breath for 5 years. He was diagnosed with idiopathic heart failure three years ago, leading to diuretic treatment. Physical examination revealed notable left lower extremity swelling, severe varicose veins, and cardiac murmurs. Echocardiography showed significant cardiac enlargement and severe functional mitral and tricuspid valve regurgitation. Computed tomography (CT) imaging uncovered a 10 mm left common iliac arteriovenous fistula, causing abnormal early filling of the inferior vena cava (IVC) and marked IVC dilation...
April 9, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38589914/optimal-patient-selection-for-maze-procedure-in-patients-undergoing-mitral-valve-disease
#6
JOURNAL ARTICLE
Tomoaki Masuda, Atsushi Aoki, Tadashi Omoto, Kazuto Maruta
OBJECTIVES: Although risk factors for unsuccessful Maze procedure have been demonstrated, an appropriate patient selection is still controversial. In our institute, Maze procedure is indicated for those whom normal sinus rhythm (NSR) was reestablished by intraoperative direct cardioversion (DC) after ventricular unloading by total cardiopulmonary bypass. The purpose of this study was to evaluate the effectiveness of our indication criteria for Maze procedure in patients with mitral valve disease...
April 8, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38535015/congenital-heart-defects-in-patients-with-molecularly-confirmed-sotos-syndrome
#7
JOURNAL ARTICLE
Giulio Calcagni, Federica Ferrigno, Alessio Franceschini, Maria Lisa Dentici, Rossella Capolino, Lorenzo Sinibaldi, Chiara Minotti, Alessia Micalizzi, Viola Alesi, Antonio Novelli, Anwar Baban, Giovanni Parlapiano, Domenico Coviello, Paolo Versacci, Carolina Putotto, Marcello Chinali, Fabrizio Drago, Andrea Bartuli, Bruno Marino, Maria Cristina Digilio
Sotos syndrome is an autosomal dominant condition characterized by overgrowth with advanced bone age, macrodolicocephaly, motor developmental delays and learning difficulties, and characteristic facial features caused by heterozygous pathogenetic variants in the NSD1 gene located on chromosome 5q35. The prevalence of heart defects (HDs) in individuals with Sotos syndrome is estimated to be around 15-40%. Septal defects and patent ductus arteriosus are the most commonly diagnosed malformations, but complex defects have also been reported...
March 11, 2024: Diagnostics
https://read.qxmd.com/read/38516797/echocardiography-past-present-and-future
#8
JOURNAL ARTICLE
Linda D Gillam, Leo Marcoff
No abstract text is available yet for this article.
March 22, 2024: Circulation. Cardiovascular Imaging
https://read.qxmd.com/read/38476375/simultaneous-management-of-aortic-and-mitral-regurgitation-through-one-stage-transcatheter-aortic-valve-replacement-and-transcatheter-edge-to-edge-repair-case-report
#9
Hao Lin, Mei Zhu, Meng Lv, Zhengjun Wang
This case report presents a 72-year-old male patient who presented with exertional dyspnea for over 10 years, which had progressively worsened over the past 4 months. Transthoracic echocardiography revealed severe aortic and mitral regurgitation, with a left ventricular ejection fraction of 37% and a left ventricular end-diastolic diameter of 64 mm. Despite receiving long-term optimal medical management, there was no improvement in symptoms or severity of valvular regurgitation. Given the relatively high surgical risk associated with double valve replacement in this elderly patient and his preference for minimally invasive procedures, a one-stage transapical aortic valve replacement and transcatheter mitral valve repair using the edge-to-edge technique were planned...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38463045/case-report-blood-pressure-variation-during-cardiopulmonary-bypass-in-a-patient-with-multiple-sclerosis
#10
Florian Helms, Stefan Rümke, Bettina Schill, Christian Kühn
INTRODUCTION AND IMPORTANCE: Multiple sclerosis is known to be associated with both sympathetic and parasympathetic cardiovascular autonomic dysregulation. Thus, patients with multiple sclerosis comorbidity represent a potentially challenging patient population in cardiac surgery, especially in on-pump operations. Despite this, very little is known about the hemodynamics during cardiopulmonary bypass and the optimal perfusion strategy for patients with multiple sclerosis undergoing cardiac operations...
March 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38458348/long-term-outcomes-following-valve-sparing-root-replacement-with-concomitant-mitral-repair
#11
JOURNAL ARTICLE
Maral Ouzounian, Myriam Lafreniere-Roula, Malak Elbatarny, Carolyn M David, Jennifer Cy Chung, Tirone E David
OBJECTIVES: To examine the late outcomes of valve-sparing root replacement and concomitant mitral valve repair in patients who have been followed prospectively for more than two decades. METHODS: From 1992 to 2020, 54 consecutive patients (mean age 47±16 years; 80% male) underwent valve-sparing root replacement (45 reimplantation; 9 remodeling) with concomitant repair of the mitral valve. Patients were followed prospectively for a median (IQR) of 9 [3 - 14] years...
March 6, 2024: Journal of Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/38455816/a-case-of-gemella-morbillorum-causing-multi-valvular-endocarditis
#12
Gabriel Panama, Adolfo Martinez, Majid Yavari, Andrew Geunwon Kim, George Abela
This is the case of a 31-year-old man with no significant past medical history who presented to the emergency department experiencing persistent fevers, chills, and malaise for the past 2-3 weeks. During this period, he had multiple urgent care visits for possible left-sided otitis media which was treated with short a course of Augmentin. While on antibiotics his symptoms would improve, but they would reappear once he had finished treatment. The patient also had significant dental carries with a chronic right molar infection...
February 2024: Curēus
https://read.qxmd.com/read/38436690/-conservative-treatment-of-valvular-heart-disease-in-adults
#13
REVIEW
Johannes Kirchner, Tanja K Rudolph
Currently, there is no specific medication approved for the treatment of valvular heart disease per se. Except for secondary mitral valve insufficiency and tricuspid valve insufficiency in pulmonary hypertension, drug therapy for higher-grade valvular heart disease is limited to diuretic therapy for symptom control. Conservative therapy for comorbidities and potential heart failure can be beneficial regardless of the specific valve lesion. In cases of aortic valve stenosis or insufficiency, controlling arterial hypertension is important...
March 4, 2024: Inn Med (Heidelb)
https://read.qxmd.com/read/38418678/clover-stitch-technique-for-aortic-valve-in-mitral-valve-repair
#14
JOURNAL ARTICLE
Taro Nakatsu, Etsuro Suenaga, Yuta Kitagata
In the case of mitral repair with severe aortic regurgitation, aortotomy and selective cardioplegia are necessary for myocardiac protection. In this situation, the saline test for mitral valve repair cannot be accomplished due to incomplete left ventricular filing. In patients undergoing mitral valve repair concomitant with severe aortic valve insufficiency, after cardiac stand still was achieved by selective cardioplegia. Each center of the aortic leaflet, termed the node of Arantius, was stitch up using a 5-0 polypropylene suture, forming a clover leaflet shape...
February 28, 2024: General Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/38388469/association-of-pulmonary-hypertension-with-the-outcome-in-patients-undergoing-edge-to-edge-mitral-valve-repair
#15
JOURNAL ARTICLE
Timm Ubben, Christian Frerker, Buntaro Fujita, Stephan Rosenkranz, Roman Pfister, Stephan Baldus, Hannes Alessandrini, Karl-Heinz Kuck, Stephan Willems, Ingo Eitel, Tobias Schmidt
OBJECTIVES: The association of pulmonary hypertension (PH) with the outcome after mitral transcatheter edge-to-edge repair (M-TEER) focusing on the new ESC/ERS guidelines definition for PH. BACKGROUND: PH is frequently found in patients with mitral regurgitation and is associated with lower survival rates. Recent studies were based on echocardiographic parameters, but results based on invasive haemodynamics differentiating distinct types of PH using the new definition for PH are missing...
February 22, 2024: Heart
https://read.qxmd.com/read/38380139/concomitant-atrial-fibrillation-ablation-in-minimally-invasive-cardiac-surgery
#16
EDITORIAL
Andrew Tjon Joek Tjien, Ferdi Akca, Kayan Lam, Jules Olsthoorn, Lukas Dekker, Pepijn van der Voort, Niels Verberkmoes, Thomas J van Brakel
Concomitant atrial fibrillation (AF) ablation in cardiac surgery effectively restores sinus rhythm and may reduce morbidity and mortality. Cardiac surgery has witnessed the transition from the historical Cox Maze procedure to more modern and less invasive approaches for concomitant AF treatment. As minimally invasive cardiac surgery gains traction, ablation methods and careful patient selection become crucial to optimize results. Emerging techniques, including bipolar epicardial radiofrequency and endo/epicardial cryoablation, are central to these advances, targeting specific arrhythmogenic areas within the atria...
January 30, 2024: Annals of Cardiothoracic Surgery
https://read.qxmd.com/read/38373718/risk-factor-analysis-for-30-day-mortality-after-surgery-for-infective-endocarditis
#17
JOURNAL ARTICLE
Jill Jussli-Melchers, Christine Friedrich, Kira Mandler, Mohamad Hosam Alosh, Mohamed Ahmed Salem, Jan Schoettler, Jochen Cremer, Assad Haneya
BACKGROUND:  Infective endocarditis (IE) remains a challenging disease associated with high mortality. Several scores have been suggested to assess surgical risk. None was sufficiently adequate. We therefore analyzed risk factors for 30-day mortality. METHODS:  A total of 438 consecutive patients had surgery for IE in our department between 2002 and 2020. Patients were divided into two groups, one consisting of 30-day survivors (362 patients; 82.6%) and one of nonsurvivors (76 patients; 17...
February 19, 2024: Thoracic and Cardiovascular Surgeon
https://read.qxmd.com/read/38361693/the-ross-procedure-in-a-case-of-baraitser-winter-syndrome-a-case-report
#18
Raghad A Alotabi, Orjowan Z Alamri, Shahad E Alenezi, Ihab Suliman
Baraitser-Winter syndrome (BRWS) is a rare genetic disorder caused by mutations in the ACTB and ACTG1 genes. It is characterized by intellectual disability, physical malformations, and dysmorphic craniofacial features. Additionally, cardiovascular abnormalities may also be present. We present a case of a 15-year-old boy with BRWS associated with congenital bicuspid aortic valve and severe aortic insufficiency which was managed successfully with Ross procedure.
January 2024: Curēus
https://read.qxmd.com/read/38352455/decreased-left-atrial-cardiomyocyte-fgf13-expression-increases-vulnerability-to-postoperative-atrial-fibrillation-in-humans
#19
Matthew A Fischer, Adrian Arrieta, Marina Angelini, Elizabeth Soehalim, Douglas J Chapski, Richard J Shemin, Thomas M Vondriska, Riccardo Olcese
Postoperative atrial fibrillation (POAF) is the most common complication after cardiac surgery and a significant cause of increased morbidity and mortality. The development of novel POAF therapeutics has been limited by an insufficient understanding of molecular mechanisms promoting atrial fibrillation. In this observational cohort study, we enrolled 28 patients without a history of atrial fibrillation that underwent mitral valve surgery for degenerative mitral regurgitation and obtained left atrial tissue samples along the standard atriotomy incision in proximity to the right pulmonary veins...
January 31, 2024: bioRxiv
https://read.qxmd.com/read/38315074/our-10-year-experience-with-atrial-myxomas-is-concurrent-valve-intervention-really-warranted
#20
JOURNAL ARTICLE
Ketika Potey, Narender Jhajhria, Manish Mallik, Rahul Bhushan, Palash Aiyer, Vijay Grover
INTRODUCTION: Primary cardiac myxomas are rare tumors. Concurrent valvular lesion is a common finding on evaluation which is thought to be due to annular dilatation secondary to tumor movement across the valve, functional obstruction across the valve, and severe pulmonary hypertension secondary to chronic obstruction. A common belief among surgeons is that excision of myxoma leads to abatement of symptoms, and further valve intervention may not be warranted. METHODS: A 10-year retrospective descriptive study was designed to analyze patients who underwent excision of cardiac myxoma at our center...
February 5, 2024: Brazilian Journal of Cardiovascular Surgery
keyword
keyword
41481
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.